Campbell & CO Investment Adviser LLC Grows Holdings in Bath & Body Works, Inc. $BBWI

Campbell & CO Investment Adviser LLC lifted its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 209.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 27,079 shares of the company’s stock after acquiring an additional 18,315 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Bath & Body Works were worth $811,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Cerity Partners LLC boosted its position in shares of Bath & Body Works by 126.4% during the first quarter. Cerity Partners LLC now owns 79,559 shares of the company’s stock worth $2,412,000 after buying an additional 44,414 shares during the period. Xponance Inc. lifted its stake in Bath & Body Works by 155.6% during the 1st quarter. Xponance Inc. now owns 25,326 shares of the company’s stock worth $768,000 after acquiring an additional 15,418 shares in the last quarter. Mutual of America Capital Management LLC grew its position in Bath & Body Works by 235.8% in the 1st quarter. Mutual of America Capital Management LLC now owns 111,471 shares of the company’s stock valued at $3,380,000 after acquiring an additional 78,280 shares in the last quarter. New York State Common Retirement Fund increased its stake in Bath & Body Works by 4.2% during the first quarter. New York State Common Retirement Fund now owns 523,592 shares of the company’s stock worth $15,875,000 after purchasing an additional 20,930 shares during the period. Finally, CWM LLC lifted its position in shares of Bath & Body Works by 105.7% during the first quarter. CWM LLC now owns 74,331 shares of the company’s stock worth $2,254,000 after purchasing an additional 38,196 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on BBWI. UBS Group reduced their price objective on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research note on Friday, August 29th. Wells Fargo & Company lowered their price objective on Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research report on Monday, October 27th. Barclays cut their target price on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Monday, October 20th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $26.00 price target on shares of Bath & Body Works in a report on Monday, October 6th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Ten investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $38.18.

Bath & Body Works Stock Down 1.7%

NYSE:BBWI opened at $22.03 on Friday. The company has a market capitalization of $4.54 billion, a PE ratio of 6.54, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 52-week low of $21.71 and a 52-week high of $41.87. The stock’s 50 day moving average price is $25.65 and its 200 day moving average price is $28.61.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the company posted $0.37 EPS. The company’s quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.